EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathogenic Mechanisms and Treatment Advancements of Sjogren’s Syndrome

Derica C. Tang, Shen Hu

Health and Metabolism · 2025

DOI: 10.53941/hm.2025.100015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health and Metabolism, 2025. Verfasst von Derica C. Tang und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sjogren’s syndrome (SS) is one of the most common chronic autoimmune diseases primarily affecting the salivary and lacrimal glands, leading to dry mouth and dry eyes, with systemic involvement in severe cases. This article provides an overview of the pathogenic mechanisms underlying SS, including genetic predisposition, immune dysregulation, cytokine imbalances, autoantibody production, and metabolic alterations. Additionally, advancements in treatment strategies are discussed, ranging from symptomatic relief to targeted biological therapies, such as B-cell depletion and cytokine modulation. While significant progress has been made in understanding the pathological mechanisms of SS, challenges persist in disease classification, biomarker identification, and therapeutic development. Future research is needed to focus on refining diagnostic criteria and exploring novel therapeutic interventions to improve disease management and patient outcomes.

Zitieren

APA

Tang, D. C., & Hu, S. (2025). Pathogenic Mechanisms and Treatment Advancements of Sjogren’s Syndrome. Health and Metabolism. https://doi.org/10.53941/hm.2025.100015

Vancouver

Tang DC, Hu S. Pathogenic Mechanisms and Treatment Advancements of Sjogren’s Syndrome. Health and Metabolism. 2025. doi:10.53941/hm.2025.100015

BibTeX
@article{Tang2025,
  author = {Tang, Derica C. and Hu, Shen},
  title = {Pathogenic Mechanisms and Treatment Advancements of Sjogren’s Syndrome},
  journal = {Health and Metabolism},
  year = {2025},
  doi = {10.53941/hm.2025.100015}
}
Kostenlos starten →